Viewing data from:

VECURONIUM BROMIDE

ANDA

VECURONIUM BROMIDE | A079001 | SUN PHARMACEUTICAL INDUSTRIES LTD

2 strengths0 unique patents0 unique exclusivities

API Supply Chain4 active DMFs1 inactive

4 active API suppliers hold Drug Master Files for this ingredient.

TAPI NL BVVECURONIUM BROMIDE

DMF 99251992

ZHEJIANG XIANJU PHARMACEUTICAL CO LTDVECURONIUM BROMIDE

DMF 120501996

CURIA ITALY SRLVECURONIUM BROMIDE

DMF 120631996

ASPEN OSS BVVECURONIUM BROMIDE

DMF 200592006

DIOSYNTH BVInactiveVECURONIUM BROMIDE

DMF 120021996

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (2)

Sort:

#001 — 10MG/VIAL

0 patents0 exclusivities▴

INJECTABLE;INJECTION | Approved: Jun 17, 2009

No patent or exclusivity listings for this strength.

#002 — 20MG/VIAL

0 patents0 exclusivities▾

INJECTABLE;INJECTION | Approved: Jun 17, 2009

Change History (4)

Recent changes detected for this application.

MODIFIEDrs7/1/2026

SUN PHARM's VECURONIUM BROMIDE (NDA 079001) was removed from the REMS (Risk Evaluation and Mitigation Strategy) program requirement.

Old: Yes

New: No

MODIFIEDrs7/1/2026

SUN PHARM's VECURONIUM BROMIDE (NDA 079001) no longer carries a Restricted Substance designation.

Old: Yes

New: No

MODIFIEDtype7/1/2026

Sun Pharmaceutical's vecuronium bromide (Norcuron) product listed under NDA 079001 transitioned from prescription status to discontinued.

Old: RX

New: DISCN

MODIFIEDTE Code7/1/2026

SUN PHARM's VECURONIUM BROMIDE (NDA 079001) therapeutic equivalence code changed from AP.

Old: AP